High bone turnover is associated with low bone mass and spinal fracture in postmenopausal women

被引:56
|
作者
Ravn, P
Rix, M
Andreassen, H
Clemmesen, B
Bidstrup, M
Gunnes, M
机构
[1] ROSKILDE CTY HOSP KOGE,DEPT INTERNAL MED,ROSKILDE,DENMARK
[2] CTR CLIN OSTEOPOROSIS RES,HAUGESUND,NORWAY
关键词
tiludronate; postmenopausal osteoporosis; urinary CrossLaps; osteocalcin; bone mineral density; spinal fracture; osteoporosis;
D O I
10.1007/s002239900225
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A group of 366 healthy, white postmenopausal women, aged 50-81 years, mean age 66 years, were selected from the screened population of Scandinavians who were part of a multicenter study of the efficacy of tiludronate, a new bisphosphonate, in established postmenopausal osteoporosis, Eighty-eight women had a lumbar spine bone mineral density (BMD) above 0.860 g/cm(2), and 278 women had a BMD below 0.860 g/cm2. Spinal fracture was diagnosed from lateral spine X-ray studies and defined as at least 20% height reduction (wedge, compression, or endplate fracture) in at least one vertebra (T4-L4), Bone resorption was assessed by measurement of the urinary excretion of type I collagen degradation products by the CrossLapsTM enzyme-linked immunoassay (ELISA). Bone formation was assessed by ELISA measurement of the N-terminal-midfragment as well as the intact serum osteocalcin (OCN-MID), thus omitting the influence of the instability of osteocalcin caused by the labile 6 amino acid C-terminal sequence. The women were divided into groups with high or low bone turnover according to the concentrations of urinary CrossLapsTM or OCN-MID. Women in the quartiles with the highest concentrations of CrossLaps [519 +/- 119 mu g/mmol (SD)] or OCN-MID [44.6 +/- 7.5 ng/ml (SD)] had 10-16% lower spinal BMD compared with women in the lowest quartiles (CrossLaps 170 +/- 48 mu g/mmol (SD), and OCN-MID [22.1 +/- 3.0 ng/ml (SD)] (P < 0.0004). The prevalences of spinal fracture were 25 to 29% in the lowest quartiles, whereas the prevalences in the highest quartiles were almost double-53-54% (P < 0.006). If the women were subgrouped according to spinal BMD and prevalence of spinal fracture, corresponding results were found. Women with a BMD less than 0.860 g/cm(2), without or with spinal fracture (n = 136 and n = 142), had 36-43% higher concentration of CrossLaps (P = 0.0001) and 11-15% higher concentration of OCN-MID (P < 0.02), as compared with women with a BMD above 0.860 g/cm(2) and no spinal fracture (n = 84). In conclusion, the results indicate a strong association among high bone turnover, low bone mass, and prevalence of spinal fracture, which supports the theory that high bone turnover is a risk factor for spinal fracture and osteoporosis.
引用
收藏
页码:255 / 260
页数:6
相关论文
共 50 条
  • [1] Bone mass, fracture risk, and associated factors in postmenopausal women living with HIV
    Leite-Silva, Paula R.
    Pinheiro, Rebeca S.
    Barbosa-Ferreira, Joao M. B.
    Balieiro, Antonio
    Sabido, Meritxell
    Lacerda, Marcus V. G.
    Chaves, Yury O.
    Nogueira, Paulo A.
    Benzaken, Adele S.
    MENOPAUSE-THE JOURNAL OF THE MENOPAUSE SOCIETY, 2024, 31 (01): : 46 - 51
  • [2] Denosumab effects on bone density and turnover in postmenopausal women with low bone mass with or without previous treatment
    Tsourdi, Elena
    Makras, Polyzois
    Rachner, Tilman D.
    Polyzos, Stergios
    Rauner, Martina
    Mandanas, Stylianos
    Hofbauer, Lorenz C.
    Anastasilakis, Athanasios D.
    BONE, 2019, 120 : 44 - 49
  • [3] Effects of Denosumab Treatment and Discontinuation on Bone Mineral Density and Bone Turnover Markers in Postmenopausal Women with Low Bone Mass
    Bone, Henry G.
    Bolognese, Michael A.
    Yuen, Chui Kin
    Kendler, David L.
    Miller, Paul D.
    Yang, Yu-Ching
    Grazette, Luanda
    San Martin, Javier
    Gallagher, J. Christopher
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2011, 96 (04) : 972 - 980
  • [4] Effect of high dietary sodium on bone turnover markers and urinary calcium excretion in Korean postmenopausal women with low bone mass
    Park, S. M.
    Joung, J. Y.
    Cho, Y. Y.
    Sohn, S. Y.
    Hur, K. Y.
    Kim, J. H.
    Kim, S. W.
    Chung, J. H.
    Lee, M. K.
    Min, Y-K
    EUROPEAN JOURNAL OF CLINICAL NUTRITION, 2015, 69 (03) : 361 - 366
  • [5] Higher serum uric acid is associated with higher bone mass, lower bone turnover, and lower prevalence of vertebral fracture in healthy postmenopausal women
    Ahn, S. H.
    Lee, S. H.
    Kim, B. -J.
    Lim, K. -H.
    Bae, S. J.
    Kim, E. H.
    Kim, H. -K.
    Choe, J. W.
    Koh, J. -M.
    Kim, G. S.
    OSTEOPOROSIS INTERNATIONAL, 2013, 24 (12) : 2961 - 2970
  • [6] Higher serum uric acid is associated with higher bone mass, lower bone turnover, and lower prevalence of vertebral fracture in healthy postmenopausal women
    S. H. Ahn
    S. H. Lee
    B.-J. Kim
    K.-H. Lim
    S. J. Bae
    E. H. Kim
    H.-K. Kim
    J. W. Choe
    J.-M. Koh
    G. S. Kim
    Osteoporosis International, 2013, 24 : 2961 - 2970
  • [7] Polymorphisms Associated With Low Bone Mass and High Risk of Atraumatic Fracture
    Zofkova, I.
    Nemcikova, P.
    Kuklik, M.
    PHYSIOLOGICAL RESEARCH, 2015, 64 (05) : 621 - 631
  • [8] Influence of Obesity on Bone Turnover Markers and Fracture Risk in Postmenopausal Women
    Lopez-Gomez, Juan J.
    Perez-Castrillon, Jose L.
    de Santos, Isabel Garcia
    Perez-Alonso, Maria
    Izaola-Jauregui, Olatz
    Primo-Martin, David
    De Luis-Roman, Daniel A.
    NUTRIENTS, 2022, 14 (08)
  • [9] The gut microbiome is associated with bone turnover markers in postmenopausal women
    Chen, Lin
    Yan, Shuai
    Yang, Ming
    Yu, Fudong
    Wang, Jingjing
    Wang, Xiaoxin
    Xu, Huanbai
    Shi, Jianxia
    Pan, Ling
    Zeng, Yuexi
    Li, Siyu
    Li, Li
    You, Li
    Peng, Yongde
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2021, 13 (11): : 12601 - 12613
  • [10] Effects of Denosumab on Bone Mineral Density and Bone Turnover in Postmenopausal Women
    Wensel, Terri M.
    Iranikhah, Maryam M.
    Wilborn, Teresa W.
    PHARMACOTHERAPY, 2011, 31 (05): : 510 - 523